Pacific Diabetes Technologies — Department of Health and Human Services SBIR Phase I: 200

Description

DESCRIPTION provided by applicant People with Type diabetes T D are at high risk for acute and chronic complications that can be minimized by concurrent use of continuous insulin delivery and continuous glucose monitoring CGM However the use of two percutaneous devices is cumbersome and seldom used We are developing a single subcutaneous catheter that serves both as a CGM and as an insulin cannula The electrodes and chemicals necessary for CGM are disposed on the outer wall of the cannula Based on recent animal studies we now know that the electroactivity of insulin preservatives is incompatible with conventional amperometric sensing technology In order to minimize interference from these preservatives after bolus delivery we will work with an organic chemist to identify sensing chemistries that allow detection of glucose oxidation at low redox potentials where the preservatives have minimal to no electroactivity The chemistry will either be a a redox mediator coordinated within a pyridine or imidazole based ligand or b a horseradish peroxidase based system designed to measure reduction of H O at negative potentials Electrochemical screening will take place using solution phase cyclic voltammetry The chemistry will be optimized to immobilize sensing layers and create a durable sensor The most promising compounds will be immobilized on Au or Pt indicating electrodes followed by crosslinking to glucose oxidase The final choice of solid phase chemistry will be based in large part on maximizing the glucose cresol response ratio ensuring stable function for at least days and avoidance of leaching If a redox mediator is chosen the outer membrane will be selected to have very low permeability to oxygen due to the fact that oxygen competes with redox mediators An existing permeation cell will be used to measure oxygen and glucose membrane permeability In Yucatan pigs we will assess preservative interference during insulin delivery and days after sensor insertion The purpose of the second study at days is to determine if sensor sensitivity declines over this period which would suggest loss of reagents from the sensor In summary to minimize device burden in T D we will develop and test a sensing chemistry that avoids the large interference one sees from preservatives during insulin boluses thus allowing CGM and insulin delivery via a single catheter PUBLIC HEALTH RELEVANCE In this project a dual use catheter will be developed and tested in pigs The outer wall of this device will be used to continuously monitor glucose and the inner lumen will be a conduit through which insulin will be continuously infused The successful development of such a device would benefit Type diabetes T D patients who are at high risk for disease of the eyes kidneys nerves feet and cardiovascular system Despite the known efficacy of continuous subcutaneous insulin infusion CSII and continuous glucose monitoring CGM less than of people in the US with T D use both technologies concurrently This failure can be explained in large part by the inconvenience and body image threat from using two percutaneous andquot through the skinandquot devices Currently available glucose sensors are not able to measure glucose at the site of insulin delivery because the preservatives in insulin cause major interference in the glucose measurement In this project an alternative chemistry that avoids the preservative induced interference will be developed To the extent that the two functions can be combined into a single unified catheter it is likely that the concurrent usage of CGM and CSII would increase substantially This increased usage would be expected to reduce the incidence of acute and chronic diabetes complications